Abstract
Aortic stenosis is the most common valvular abnormality in the United States. It is commonly associated with a prolonged asymptomatic period followed by rapid development of symptoms. The primary physiologic change is left ventricular outflow obstruction for which the heart cannot compensate appropriately in times of increased demand. There are specific recommendations from the 2014 AHA/ACC Guidelines regarding surgical indications for aortic valve surgery. For poor surgical candidates, minimally invasive techniques including transcatheter aortic valve replacements are available. Hemodynamic goals for induction of anesthesia include maintenance of normal sinus rhythm, avoiding hypotension, and avoiding bradycardia and tachycardia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bonow R, Carabello B, Chatterjee K, de Leon A, Faxon D, Freed M, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons. Circulation. 2008;118(15):e523–661.
Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.
Nishimura R, Otto C, Bonow R, Carabello B, Erwin J, Guyton R, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2014;129(23):2440–92.
Binanay C, Califf RM, Hasselblad V, O’Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294(13):1625–33.
Wilson W, Taubert K, Gewitz M, Lockhart P, Baddour L, Levison M, et al. Prevention of infective endocarditis: guidelines from the American heart association: a guideline from the American heart association rheumatic fever, endocarditis, and Kawasaki disease committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007;116(15):1736–54.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Lander, H.L., Zammert, M. (2017). Anesthetic Considerations in Patients with Valvular Heart Disease. In: Aglio, L., Urman, R. (eds) Anesthesiology. Springer, Cham. https://doi.org/10.1007/978-3-319-50141-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-50141-3_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50139-0
Online ISBN: 978-3-319-50141-3
eBook Packages: MedicineMedicine (R0)